Diet-induced weight loss and markers of endothelial dysfunction and inflammation in treated patients with type 2 diabetes

Clinical Nutrition ESPEN

Volumn 15, Issue , 2016, Pages 101-106

  Berk, K A ^a   Oudshoorn, T P ^a   Verhoeven, A J M ^a   Mulder, M T ^a   Roks, A J M ^a   Dik, W A ^b   Timman, R ^c   Sijbrands, E J G ^a  

^a Division of Vascular Medicine and Pharmacology   (Netherlands)

^b Department of Immunology ^*  (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Diet; Endothelial dysfunction; Inflammation; Obesity; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INCRETIN; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA DERIVATIVE; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; DIET; DIET RESTRICTION; DISEASE DURATION; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOGLYCEMIA; INFLAMMATION; INTERVENTION STUDY; LOW CALORY DIET; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; ADOLESCENT; BLOOD; CARDIOVASCULAR DISEASE; COMPLICATION; DIET THERAPY; MIDDLE AGED; PROCEDURES; RISK FACTOR; VASCULAR ENDOTHELIUM; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIET, REDUCING; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; INSULIN; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; RISK FACTORS; VASCULAR CELL ADHESION MOLECULE-1; YOUNG ADULT;

EID: 84989311694     PISSN: 24054577     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnesp.2016.06.011     Document Type: Article

References (30)

1. [1] Barr, E.L., Zimmet, P.Z., Welborn, T.A., Jolley, D., Magliano, D.J., Dunstan, D.W., et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 116:2 (2007), 151–157.
2. [2] Katzmarzyk, P.T., Hu, G., Cefalu, W.T., Mire, E., Bouchard, C., The importance of waist circumference and BMI for mortality risk in diabetic adults. Diabetes Care 36:10 (2013), 3128–3130.
3. [3] Tousoulis, D., Papageorgiou, N., Androulakis, E., Siasos, G., Latsios, G., Tentolouris, K., et al. Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches. J Am Coll Cardiol 62:8 (2013), 667–676.
4. [4] Eringa, E.C., Serne, E.H., Meijer, R.I., Schalkwijk, C.G., Houben, A.J., Stehouwer, C.D., et al. Endothelial dysfunction in (pre)diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes. Rev Endocr Metab Disord 14:1 (2013), 39–48.
5. [5] Steiner, M., Reinhardt, K.M., Krammer, B., Ernst, B., Blann, A.D., Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Thromb Haemost 72:6 (1994), 979–984.
6. [6] Meigs, J.B., Hu, F.B., Rifai, N., Manson, J.E., Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. Jama 291:16 (2004), 1978–1986.
7. [7] Stehouwer, C.D., Gall, M.A., Twisk, J.W., Knudsen, E., Emeis, J.J., Parving, H.H., Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51:4 (2002), 1157–1165.
8. [8] Kanai, A., Kawamura, T., Umemura, T., Nagashima, M., Nakamura, N., Nakayama, M., et al. Association between future events of brain infarction and soluble levels of intercellular adhesion molecule-1 and C-reactive protein in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 82:2 (2008), 157–164.
9. [9] Frankel, D.S., Meigs, J.B., Massaro, J.M., Wilson, P.W., O'Donnell, C.J., D'Agostino, R.B., et al. Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the Framingham offspring study. Circulation 118:24 (2008), 2533–2539.
10. [10] Schillinger, M., Exner, M., Amighi, J., Mlekusch, W., Sabeti, S., Rumpold, H., et al. Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events of patients with advanced atherosclerosis. Circulation 108:19 (2003), 2323–2328.
11. [11] Schulze, M.B., Rimm, E.B., Li, T., Rifai, N., Stampfer, M.J., Hu, F.B., C-reactive protein and incident cardiovascular events among men with diabetes. Diabetes Care 27:4 (2004), 889–894.
12. [12] Pearson, T.A., Mensah, G.A., Alexander, R.W., Anderson, J.L., Cannon, R.O. 3rd, Criqui, M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 107:3 (2003), 499–511.
13. [13] Look Ahead Research Group. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol 2:10 (2014), 801–809.
14. [14] Wing, R.R., Reboussin, D., Lewis, C.E., Look, A.R.G., Intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369:24 (2013), 2358–2359.
15. [15] Gregg, E.W., Chen, H., Wagenknecht, L.E., Clark, J.M., Delahanty, L.M., Bantle, J., et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. Jama 308:23 (2012), 2489–2496.
16. [16] Raitakari, M., Ilvonen, T., Ahotupa, M., Lehtimaki, T., Harmoinen, A., Suominen, P., et al. Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol 24:1 (2004), 124–128.
17. [17] Esposito, K., Marfella, R., Ciotola, M., Di Palo, C., Giugliano, F., Giugliano, G., et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. Jama 292:12 (2004), 1440–1446.
18. [18] Bigornia, S.J., Farb, M.G., Tiwari, S., Karki, S., Hamburg, N.M., Vita, J.A., et al. Insulin status and vascular responses to weight loss in obesity. J Am Coll Cardiol 62:24 (2013), 2297–2305.
19. [19] Hamdy, O., Ledbury, S., Mullooly, C., Jarema, C., Porter, S., Ovalle, K., et al. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 26:7 (2003), 2119–2125.
20. [20] Wing, R.R., Bolin, P., Brancati, F.L., Bray, G.A., Clark, J.M., Coday, M., et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369:2 (2013), 145–154.
21. [21] Berk, K.A., Buijks, H., Ozcan, B., Van't Spijker, A., Busschbach, J.J., Sijbrands, E.J., The prevention of weight regain in diabetes type 2 (POWER) study: the effectiveness of adding a combined psychological intervention to a very low calorie diet, design and pilot data of a randomized controlled trial. BMC Public Health, 12, 2012, 1026.
22. [22] Wendel-Vos, G.C., Schuit, A.J., Saris, W.H., Kromhout, D., Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol 56:12 (2003), 1163–1169.
23. [23] Anderson, J.W., Kendall, C.W., Jenkins, D.J., Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr 22:5 (2003), 331–339.
24. [24] Belalcazar, L.M., Haffner, S.M., Lang, W., Hoogeveen, R.C., Rushing, J., Schwenke, D.C., et al. Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: from the look AHEAD study. Obes (Silver Spring) 21:5 (2013), 944–950.
25. [25] Clifton, P.M., Keogh, J.B., Foster, P.R., Noakes, M., Effect of weight loss on inflammatory and endothelial markers and FMD using two low-fat diets. Int J Obes (Lond) 29:12 (2005), 1445–1451.
26. [26] Thompson, D., Walhin, J.P., Batterham, A.M., Stokes, K.A., Cooper, A.R., Andrews, R.C., Effect of diet or diet plus physical activity versus usual care on inflammatory markers in patients with newly diagnosed type 2 diabetes: the Early ACTivity in Diabetes (ACTID) randomized, controlled trial. J Am Heart Assoc, 3(3), 2014, e000828.
27. [27] Buscemi, S., Cosentino, L., Rosafio, G., Morgana, M., Mattina, A., Sprini, D., et al. Effects of hypocaloric diets with different glycemic indexes on endothelial function and glycemic variability in overweight and in obese adult patients at increased cardiovascular risk. Clin Nutr 32:3 (2013), 346–352.
28. [28] Tousoulis, D., Hatzis, G., Papageorgiou, N., Androulakis, E., Bouras, G., Giolis, A., et al. Assessment of acute coronary syndromes: focus on novel biomarkers. Curr Med Chem 19:16 (2012), 2572–2587.
29. [29] Tousoulis, D., Kampoli, A.M., Tentolouris, C., Papageorgiou, N., Stefanadis, C., The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 10:1 (2012), 4–18.
30. [30] Johansen, O.E., Interpretation of cardiovascular outcome trials in type 2 diabetes needs a multiaxial approach. World J Diabetes 6:9 (2015), 1092–1096.